Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 2021

View Archived Issues

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Study of beta-arrestin isoforms may alter development of drugs targeting GPCRs

OR2AT4 identified as a new therapeutic target in COPD

Discovery of a potent nonopioid analgesic peptide, RgIA-5474

Bahcesehir University presents new apoptosis regulator Bcl-2 inhibitors

Lilly discovers TYK2 JH2 domain ligands

New CAPN2 inhibitors identified at Western University of Health Sciences

Bristol Myers Squibb patents rotein-arginine deiminase type-4 inhibitors

Amilo-5MER shows efficacy in animal models of SAA-associated pathologies

nCoVmab1 prevents SARS-CoV-2 infection and significantly inhibits viral replication in vivo

PITPNA-AS1 is upregulated and exerts tumorigenesis in TNBC

Algernon's in vitro study shows DMT increases growth of neurons at subhallucinogenic dose

Opaganib significantly decreases kidney fibrosis in in vivo model

IMM-BCP-01 neutralizes SARS-CoV-2 Lambda and Delta Plus variants in preclinical tests

LCMV vaccine vector expressing TRP2 enables curative melanoma treatment

Mebendazole slows progression and metastasis in pancreatic cancer

Impact BioMedical reports synthesis of first Quantum-based compound

SPKM-001 neutralizes Delta and Delta Plus variants of SARS-CoV-2 in vivo

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

AAV integration frequencies "surprisingly high," study finds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...